M. Baud is a part-time employee at the Wyss Center for Bio- and Neuro-Engineering. T. Perneger, A. Rácz, and M. Pensel report no disclosures relevant to the manuscript. C. Elger reports personal fees in the form of honoraria from UCB, Desitin, BIAL, and Eisai. C.E.E. has also received grants from the Deutsche Forschungsgemeinschaft, the Bundesministerium für Bildung und Forschung, and the Marga and Walter Boll Stiftung. C.E.E. also served as medical director for the Life & Brain Institute until 2015 and as platform leader for Cognitive Neuroscience until 2017. B. Rydenhag and K. Malmgren report no disclosures relevant to the manuscript. H. Cross has received remuneration to her department as a clinical investigator for Vitaflo, GW Pharma, and Zogenix. She has participated in advisory boards for GSK, UCB, Zogenix, GW Pharma, Nutricia, and Eisai and as speaker for Shire, Nutricia, Zogenix, and GW Pharma, again for which remuneration was made to her department. She holds grants from the European Union, National Institute for Health and Research, Action Medical Research, Great Ormond Street Hospital Charity, and SPARKS. G. McKenna, M. Tisdall, and H. Lamberink report no disclosures relevant to the manuscript. S. Rheims received consultant and/or speaker fees from UCB Pharma, EISAI, Livanova, and GW Pharma. P. Ryvlin, J. Isnard, and F. Mauguière report no disclosures relevant to the manuscript. A. Arzimanoglou occasionally serves on scientific advisory boards for Biomarin, Eisai, GW Pharma, Shire, Takeda, and UCB, as well as on Data Safety Monitoring boards for UCB. He received funding for travel or speaker honoraria from Eisai, GW Pharma, Shire, and UCB. Since 2004, he has served as editor-in-chief of the educational journal of the International League Against Epilepsy, Epileptic Disorders
(John Libbey Eurotext editions), and since 2010, he has served as associated editor of the European Journal of Paediatric Neurology
(Elsevier). He received research support from the European Commission, the Caixa Bank Foundation, and UCB. He serves as visiting professor at the Universitat de Barcelona, Spain, and as coordinator of research for the Pediatric Epilepsy Unit of the children's University Hospital San Juan de Déu, Barcelona, Spain. S. Akkol, K. Deniz, and C. Ozkara report no disclosures relevant to the manuscript. M. Lossius serves on the advisory boards for Esai and UCB, has received speaker honoraria at meetings for physicians sponsored by UCB and Eisai, and has served as an editorial advisory board member at Epilepsy Research and Treatment
, Hindawi, from 2015 until it ceased publication in 2017. I. Rektor, R. Kälviäinen, L. Vanhatalo, P. Dimova, K. Minkin, A. Staack, B. Steinhoff, A. Kalina, P. Krsek, P. Marusic, Z. Jordan, and D. Fabó report no disclosures relevant to the manuscript. E. Carrette was supported by Elekta Neuromag to cover travel and/or registration costs to give presentations at international conferences. P. Boon, S. Rocka, R. Mameniškienė, S. Vulliémoz, F. Pittau, and K. Braun report no disclosures relevant to the manuscript. M. Seeck reports shares for Epilog, EEG diagnostic technology. Go to Neurology.org/N
for full disclosures.